A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer

NCT01424930 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Neoplasms
Prostate Cancer

Interventions

DRUG: Abiraterone
DRUG: Prednisone

Sponsor

Janssen-Ortho Inc., Canada